Pharmacists and Physicians who are not currently abortion providers who wish to dispense Mifegymiso will be required to take a 6-hour training (3 hours for physicians who are currently providers). No other similar drug requires this amount of training. Following that training, the physician will be added to a confidential registry. This confidential directory undermines effective referrals. Action Canada for Sexual Health and Rights is working with Celopharma to develop measures to mitigate the impact of the registry restriction through greater public information.